BackAbCellera Biologics Overview

AbCellera Biologics Long Term Debt

AbCellera Biologics's long-term debt is $130M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$129.95M
↓ 5.27% YoYΔ $-7.24M vs prior year quarter

Peer trimmed avg / median

Loading

AbCellera Biologics Long Term Debt History

Loading

AbCellera Biologics vs. peers: Long Term Debt Comparison

Loading

AbCellera Biologics Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

AbCellera Biologics (ABCL) FAQ

As of the most recent data (June 2026), ABCL shows a long-term debt of $130M. That compares with $140M in the prior-year period — down 5.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ABCL's long-term debt is now $130M (was $140M) — a 5.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether AbCellera Biologics is outperforming or lagging.

Tracking ABCL's long-term debt over time shows whether AbCellera Biologics is scaling, shrinking, or reshaping that part of the business. The current reading is $130M That compares with $140M in the prior-year period — down 5.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has AbCellera Biologics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $130M) with ownership activity and broader fundamentals.